• Magazine
    • Past Issues
    • Subscribe
    • Change Mailing Address
    • Surveys
    • Guidelines for Authors
    • Editorial Calendar
    • Editorial Deadlines
    • Dynamic Chiropractic
      • Newspaper
      • Subscription
    • The American Chiropractor
      • Magazine
  • Practice
    • Business Tips
    • Chiropractic Schools
    • Clinical & Technique
    • eBooks
    • eCourses
    • Sponsored Content
    • Infographics
    • Quizzes
    • Wellness & Nutrition
    • Personal Growth
    • Podcast
    • Coronavirus (COVID-19)
  • Resource Centers
  • Products & Services
    • Buyer’s Guide
    • Products Directory
    • Submit a Product
    • Vendor Login
  • Datebook
    • Become an Events Poster
    • Post an Event
    • View Events
  • Jobs
    • Jobs
    • Post a Job
  • Advertise
    • Advertising Information
    • Media Kit
    • Contact Us

Your Online Chiropractic Community

Chiropractic Economics Your Online Chiropractic Community
Subscribe
  • Home
  • Current Issue
  • News
  • Webinars
  • Chiropractic Research
  • Students

Statement from UAS Laboratories president regarding recent FDA action

Chiropractic Economics June 15, 2011

UAS_Laboratories_LogoIn response to certain information contained on the UAS Laboratories website, the FDA seized UAS Labs’ products last week. UAS Labs is diligently working with the FDA to correct this information. In the interim, it is important for our customers, vendors, and colleagues to understand the facts.

1. Our product is not under question. Our facilities were recently inspected by the FDA and our products are safe and effective. People do not need to worry about the probiotics they are taking.

2. What is at issue with the FDA are certain statements made on our website that the FDA believes expand our labeling to imply that our products can be used to treat or cure certain health conditions.

We are removing and/or modifying this language to be in compliance with FDA requirements and are working with the FDA to resolve this issue. We are in contact with our FDA representatives and expect to resolve this matter very soon. While we respect the FDA’s position, it is unfortunate that the matter could not have been resolved with a phone call or warning letter before taking action.

Source: Dr. Dash – UAS Laboratories, www.uaslabs.com

Related Posts

  • Metagenics to host free webinar with Mark Hyman, PhDMetagenics to host free webinar with Mark Hyman, PhD
  • Carlson Labs receives multiple awards from ITQICarlson Labs receives multiple awards from ITQI
  • Dates announced for Meniere’s disease lyceumDates announced for Meniere’s disease lyceum
  • Non-chiropractic training and seminarsNon-chiropractic training and seminars
  • Carlson Laboratories announces loss of co-founder John CarlsonCarlson Laboratories announces loss of co-founder John Carlson
  • For doctors: types of business taxes and getting aheadFor doctors: types of business taxes and getting ahead

Filed Under: Industry News, News

Current Issue

CE issue 8 cover

Follow Us

  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • YouTube logoYouTube logoYouTube

Compare Subscriptions

Dynamic Chiropractic

The American Chiropractor

3948 3rd Street South #279,

Jacksonville Beach, FL 32250

Phone 904.285.6020

CONTACT US »

Privacy Policy & Terms of Service

Copyright © 2021, All Rights Reserved

SUBSCRIBE TO THE MAGAZINE

Get Chiropractic Economics magazine
delivered to your home or office. Just
fill out our form to request your FREE
subscription for 20 issues a year,
including two annual Buyers Guides.

SUBSCRIBE NOW »

Latest Chiropractic News

  • Foundation for Chiropractic Progress Hits Monumental Membership Milestone
  • Clinical Studies Support Charlotte’s Web CBD Clinic™ Topicals as Safe for Massage and Frequent Use
  • Troy Healthcare Launches the Stopain® Clinical ‘Points of Relief’ Resource Center and Newsletter for DCs